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Objective: Studies have shown that patients with failing Fontan circulation may de-
velop liver cirrhosis with its sequelae. Therefore, early detection of fibrosis is essential
to identify patients at risk. Transient elastography has been evaluated for noninvasive
staging of liver fibrosis in a multitude of studies.
Methods:A total of 39 patients who underwent the Fontan procedure were included in
the study. All patients underwent an abdominal ultrasound, transient elastography,
and detailed laboratory testing. Conventional echocardiography assessment of inflow
and outflow and ventricular function were performed.
Results: Significant signs of liver fibrosis were found in 36 of 39 children according to
the elastography method and in 28 of 39 children according to the measured biochem-
ical fibrosis markers. The Spearman correlation coefficient between the liver stiffness
measured with transient elastography and the time interval since the Fontan operation
was highly significant (0.514, P 5 0.001).
Conclusion: The present study shows that patients who undergo the Fontan procedure
are at increased risk of developing liver fibrosis and liver cirrhosis. The risk increases
with the age of the patient and the time interval since the Fontan procedure. The non-
invasive measurement of liver fibrosis using transient elastography and fibrosis
marker scores can be a useful tool to identify patients at risk and for noninvasive
surveillance.
T
he Fontan operation was first reported in 1968 by Fontan and has undergone
several surgical modifications to bypass the inferior venous blood return to the
lung using intracardial and extracardial conduits to the common atrium. It has
been shown to be an effective palliative operation for children with a morphologically
and functionally univentricular heart. However, during long-term follow-up, altered
univentricular diastolic function1,2 and absence of pulsation in the pulmonary circu-
lation1 may lead to increased pulmonary vascular resistance associated with hemody-
namic changes, including central venous and liver congestion.3-6 Long-lasting liver
congestion and altered venous flow may lead to structural and functional alteration
of the liver. The precise pathophysiologic mechanism is not clear. Studies have shown
a correlation of the systemic venous pressure and the duration of the Fontan circula-
tion with liver fibrosis and cirrhosis.4,6 Thus, staging of liver fibrosis is important in
patients after the Fontan operation to identify patients at risk.
At present, liver biopsy is still the gold standard for the assessment of liver fibrosis.
However, it is an invasive method associated with discomfort for the patient, and in
rare cases serious complications have been reported.7 In addition, the accuracy of liver
biopsy is limited because of significant intra- and interobserver variability and
sampling errors.8 Therefore, research has been focused on the evaluation of noninva-
sive methods for the assessment of liver fibrosis. The different approaches include
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DAbbreviation and Acronym
ALT 5 alanine aminotransferase
routine hematologic and biochemical tests, surrogate fibrosis
markers in the blood and respective algorithms, and recently
transient elastography (FibroScan, Echosens, Paris, France).
A combination of different blood markers and the assessment
of tissue elasticity based on transient elastography have
shown the best results in accurate determination of the degree
of liver fibrosis in adults with different liver diseases.9 Stud-
ies have shown that transient elastography and serum fibrosis
markers can be used in children just as well as in adults.10,11
In the present study we assessed possible fibrotic changes in
the liver in patients with Fontan circulation using the combi-
nation of transient elastography and biochemical serum fibro-
sis markers.
Materials and Methods
Patients
Thirty-nine patients who underwent the Fontan procedure and at-
tended the Department of Pediatric Cardiology at the Saarland Uni-
versity Hospital for follow-up in 2006 were consecutively enrolled
in the study. The baseline characteristics of the patients are shown in
Table 1.
Other causes of liver disease (chronic hepatitis B and C, hemo-
chromatosis, Wilson’s disease, deficiency in alpha-1 antitrypsin,
and autoimmune liver disease) were excluded serologically in all
patients.
All patients received a B-mode sonography of the liver and
spleen including duplex Doppler sonography of the liver and tran-
sient elastography. Blood parameters were obtained on the same
day as the performance of ultrasound and transient elastography
(for further description see ‘‘Blood Markers’’ in this section). All
patients underwent standard echocardiography examination, includ-
ing Doppler assessment of inflow and outflow in the univentricular
heart.
The present study was performed in accordance with the ethical
guidelines of the Helsinki Declaration. Informed consent from the
parents was obtained for the examinations and blood sampling.
Sonographic Examination
All patients were examined by B-mode and duplex Doppler sonog-
raphy using a 3.5-MHz transducer (Hitachi EUB-8500, Tokyo,
Japan) in a supine position. All patients had fasted overnight. Focal
lesions and vascular malformations in the liver were excluded by
careful sonographic scanning of the liver. The liver parenchyma
was examined for echogenicity, homogeneity, liver surface nodular-
ity, hypertrophy of segment I, and signs of portal hypertension. The
spleen length was measured and documented as absolute length and
as relative length in relation to the age-adjusted medium length of
a healthy subject of the same age.12
For duplex scanning the sample gate was adjusted to 2 to 6 mm
depending on the diameter of the examined blood vessel. Spectral
analysis was recorded and repeated twice to confirm the reproduc-The Journal of Thoribility of the Doppler sonography spectrum. Doppler sonography
of the right hepatic vein was performed via the intercostal approach
in a 30-degree left lateral position of the patient with the right arm
raised above the head. The diameter of the right hepatic vein was
measured in this position 2 to 3 cm distal to the confluence of the
hepatic veins. The Doppler sonography spectrum was recorded if
possible in short breathing pauses of 5 seconds. The flow pattern
was measured 2 to 3 cm distal to the confluence of the hepatic veins.
The maximum and minimum (reversed flow) velocity (centimeters/
second) were recorded in each patient.
The portal vein diameter and flow pattern were measured at the
corresponding site next to the right hepatic vein. The Doppler sono-
graphic spectrum of the portal vein was documented if possible
during a 5-second breathing pause to avoid influences of respiration
and intra-abdominal pressure. The maximum (Vmax) and medium
(Vmed) velocities (centimeters/second) were recorded in each
patient.
Transient Elastography
The FibroScan is a medical device based on transient elastography.
It is equipped with a probe including an ultrasonic transducer
mounted on the axis of a vibrator. A vibration transmitted from
the vibrator toward the tissue induces an elastic shear wave that
propagates through the tissue. These propagations are followed by
pulse-echo ultrasound acquisitions, and their velocity is measured
(which is directly related to tissue stiffness). The harder the tissue,
the faster the shear wave propagates. The results are expressed in
kilopascals.9,13-15 Transient elastography has been evaluated in
a multitude of liver diseases, and different studies evaluating the re-
producibility of transient elastography have reported high intraob-
server (96%–98%) and interobserver (89%–98%) agreement.16,17
Recently, this method was validated in children with liver fibro-
sis receiving liver biopsy with similarly good diagnostic accuracy as
in adults.10
The patients were examined in a supine position with the right
arm elevated above the head. Patients were instructed to continue
breathing as usual. The examination was performed on the right
lobe of the liver through the intercostal space in all patients. An
area was chosen where the liver tissue was free of large blood ves-
sels. After the area of measurement was located, the examiner
pressed the button of the probe to start the acquisition. The measure-
ment depth was between 25 and 65 mm. Ten successful acquisitions
were performed on each patient. The success rate was automatically
calculated by the machine as the ratio of the number of successful
acquisitions over the total number of acquisitions. Only transient
elastography results obtained with 10 valid measurements and
with a success rate of at least 60% were considered. These are qual-
ity criteria evaluated by previous studies. The median of all success-
ful measurement was automatically calculated by the machine as
representative of the liver elasticity module. The entire examination
lasted approximately 5 minutes per patient.
Because the probe of the FibroScan was developed for adults and
the liver stiffness measurement was standardized between 25 and 65
mm below the skin surface, overestimation of the transient elastog-
raphy values in young children was expected. Therefore, the raw
data of each measurement were analyzed and the liver stiffness
was recalculated between 25 and 55 mm below the skin surface in
children less than 7 years of age. This was performed in accordanceacic and Cardiovascular Surgery c Volume 135, Number 3 561
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DTABLE 1. Patients' baseline characteristics
Characteristics Mean 6 SD Median Range
Demographics (n 5 39 patients)
Male 20 patients
Female 19 patients
Age (y) 11.6 6 5.5 11.0 3–23
Time interval since Fontan operation (mo) 67.9 6 41.3 69.0 2–180
BMI (kg/m2) 17.4 6 3.2 16.5 13–26
Echocardiographic parameters
Functionally univentricular right heart 13 patients
Functionally univentricular left heart 22 patients
Intracardiac tunnel (extracardiac tunnel) 37 (2) patients
Fenestration open 35 patients
Biochemistry
ALT (U/L) 28.9 6 12.7 27.0 9–69
ALT (3ULN) 0.90 6 0.46 0.88 0.3–2.16
Aspartate aminotransferase (U/L) 46.9 6 14.0 44.0 21–76
Aspartate aminotransferase (3ULN) 1.09 6 0.45 1.10 0.3–1.8
Gamma-glutamyl transpeptidase (U/L) 57.8 6 34.3 47.5 16–144
Gamma-glutamyl transpeptidase (3ULN) 1.97 6 1.55 1.64 0.2–7.11
Bilirubin total (mg/dL) 0.98 6 0.64 0.90 0.1–2.5
Lactate dehydrogenase (3ULN) 1.06 6 0.43 1.06 0.3–2.0
Alkaline phosphatase (3ULN) 0.74 6 0.38 0.75 0.3–2.2
Albumin (g/L) 46.1 6 4.5 47.0 34–52
Hemoglobin (g/dL) 15.4 6 1.6 15.7 12.4–19.6
Leucocyte count (103/mm3) 7.7 6 2.9 6.65 3.3–14.7
Platelet count (103/mm3) 260.3 6 100.0 248.5 120–514
C-reactive protein (mg/L) 4.5 6 6.3 1.5 0.6–30.8
INR 1.97 6 0.6 1.91 1.11–4.6
PTT (sec) 36.0 6 4.9 36.0 28–49
Factor V (%) 69.6 6 14.8 72.0 45–98
Antithrombin III (%) 103.8 6 10.6 103.0 84–124
Immunoglobulin G (mg/dL) 1024 6 217 1035 543–1580
Immunoglobulin M (mg/dL) 94.1 6 33.6 89.5 41–168
Glucose (mmol/L) 3.5 6 1.4 3.8 1.0–5.72
Triglycerides (mmol/L) 0.74 6 0.47 0.62 0.2–2.75
Cholesterol (mmol/L) 3.25 6 0.99 3.33 2.0–6.08
SD, Standard deviation;BMI, body mass index;ULN, upper limit of normal; ALT, alanine aminotransferase; INR, international normalized ratio; PTT, prothrombin
time.with a previous study of children who received a liver biopsy and
a transient elastography.10
The staging of liver fibrosis was performed according to the
study of Foucher and colleagues.15 In this study, transient elastogra-
phy values were analyzed in comparison with histology using the
semiquantitative histologic staging system of METAVIR:18 F0 5
no fibrosis, F1 5 portal fibrosis without septa, F2 5 portal fibrosis
with few septa, F35 numerous septa without cirrhosis, F45 cirrho-
sis. The most discriminant cutoff values for transient elastography in
the study of Foucher and colleagues were 7.2 kPa for F $ 2, 12.5
kPa for F $ 3, and 17.6 for F 5 4.9 These cutoff values were
used for staging of liver fibrosis in the present study.
Echocardiography
All patients were examined using a 3.5 or 2.5-MHz transducer inter-
faced with a Vingmed ultrasound system (GE-Vivid 7, Horten, Nor-562 The Journal of Thoracic and Cardiovascular Surgery c Marway). Standard transthoracic imaging from the parasternal, apical,
and subcostal views was performed in the left lateral decubitus po-
sition. Initial routine diagnostic imaging included color flow map-
ping and pulsed-wave Doppler of the inflow of the lung veins in
the common atrium, inflow at the atrioventricular valve, and outflow
at the aortic valve for possible regurgitation. In an apical ‘‘4-cham-
ber’’ view, the atrioventricular valve inflow velocity profiles were
recorded with the Doppler sample placed at the tip of the atrioven-
tricular valves with simultaneous electrocardiogram recordings in
each patient. In case of double-inlet morphology the inflow from
the left atrium was considered for the measurement of inflow pat-
terns. Atrioventricular inflow was analyzed in 5 heart cycles for
the maximal inflow velocity (E wave), late atrial wave (A wave),
and E/A ratio. The usual size of the pulsed Doppler gate was 1.5
mm, and the filter was set at 100 Hz. For optimal acquisition, care
was taken to direct the transducer beam as closely as possible toch 2008
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Dthe Doppler beam, at less than 20 degrees in selected planes. All
measurements were recorded digitally in the EchoPac program for
subsequent off-line data analysis. The mean value of each parameter
was calculated in 5 consecutive cycles.
Blood Markers
The following blood parameters were determined after overnight
fasting in the same laboratory: aspartate aminotransferase, alanine
aminotransferase (ALT), g-glutamyl transpeptidase, total bilirubin,
lactate dehydrogenase, alkaline phosphatase, albumin, hemoglobin,
platelet count, leucocyte count, C-reactive protein, international nor-
malized ratio, prothrombin time, factor V, antithrombin III, immu-
noglobulin G and M, cholesterol, triglycerides, fasting glucose,
a2-macroglobulin, apolipoprotein A1, and haptoglobin.
Enzymatic activity was measured at 37C according to Interna-
tional Federation of Clinical Chemistry standards.
The laboratory followed the preanalytic and analytic recom-
mendations required to obtain the fibrosis marker score results.19
The FibroTest and ActiTest (Biopredictive, Paris, France), the
serum necroinflammatory marker score, were computed on the
Biopredictive website (www.biopredictive.com). The security al-
gorithms on the industrial website permitting the exclusion of pa-
tients with a high-risk profile of false-positive and negative results
were respected. This formula has been evaluated in various liver
diseases for the diagnosis of liver fibrosis and is currently the
best evaluated noninvasive serum fibrosis marker algorithm and
is commercially available throughout the world.19,20 In studies
comparing these noninvasive serum markers with the reference
method liver biopsy, the FibroTest showed good diagnostic accu-
racy for the assessment of liver fibrosis, whereas the ActiTest was
found to be a useful tool for the assessment of necroinflammatory
activity in the liver.19-21
Statistical Analysis
Statistical analysis was performed using the Statistical Package for
the Social Sciences (version 12.0, SPSS Inc, Chicago, Ill). Clinical
and laboratory characteristics of patients were expressed as mean6
standard deviation. All tests were 2-sided. Relationships between
variables were examined using the Spearman’s rank correlation co-
efficient. The relation of the time interval since the Fontan operation
and the fibrosis staging using the transient elastography and the
necroinflammatory grading using the ActiTest are illustrated as
the median and 25th to 75th percentile values (box-plot). The rela-
tion of the time interval since the Fontan operation and the fibrosis
staging using the fibrosis marker score are demonstrated in a range
diagram.
TABLE 2. Liver fibrosis stageswith FibroScan and FibroTest
Method F 0/1 F 1-2 F 2 F 3 F3-4 F 4 Mean 6 SD Median
FibroScan
(Echosens,
Paris, France)
13% — 26% 20% — 41% 2.9 6 1.0 3.0
FibroTest
(Biopredictive,
Paris, France)
32% 35% 6% 21% 3% 3% 1.7 6 1.0 1.5
SD, Standard deviation. P value , .001 for all values.The Journal of ThoResults
Altogether, 39 patients who underwent the Fontan procedure
and attended the Department of Pediatric Cardiology at the
Saarland University Hospital for follow-up in 2006 were
consecutively enrolled in the study. Thirteen patients had
a functionally univentricular right heart, 22 patients had a func-
tionally univentricular left heart, and 4 patients had a function-
ally univentricular right heart. The baseline characteristics of
the patients are shown in Table 1.
Successful measurement of liver stiffness using transient
elastography was performed in all examined children. Signif-
icant signs of liver fibrosis were found in 36 of 39 children
according to the elastography method and in 28 of 39 chil-
dren according to the measured biochemical fibrosis markers
in the studied patients after the Fontan operation. The number
of patients assigned to each fibrosis stage according to Meta-
vir using transient elastography and the fibrosis marker score
is shown in Table 2.
Liver stiffness measured with transient elastography cor-
related significantly with the biochemical fibrosis markers
(0.344, P , .05) and the necroinflammatory serum marker
(0.480, P , .05).
Factors Influencing Liver Stiffness, Fibrosis,
and Necroinflammatory Activity in Patients
After the Fontan Operation
Liver stiffness measured with transient elastography corre-
lated significantly with the patient’s age (0.439, P , .05)
and the time interval since the Fontan operation (0.544,
P 5 .002) (Figure 1). In addition, significant positive corre-
lation was found between the liver stiffness measured with
transient elastography and the laboratory values ALT
(0.411, P , .05) and factor V (-0.429, P , .05).
A relationship between the liver fibrosis measured with
transient elastography and echocardiographic parameters
was found for the inspiration/expiration diameter ratio of
the vena cava (0.456, P 5 .05) and for the E/A value across
the atrioventricular systemic valve (0.372, P, .05). No cor-
relation was found between the liver stiffness and the ejection
fraction of the univentricular heart or other echocardiographic
markers of global systolic and diastolic function, the gradient
at the Fontan fenestration, the flow velocities in the liver
veins, and the estimated hepatic venous blood flow.
The serum fibrosis marker correlated significantly with the
age of the patient (0.453, P, .01) at the time of examination,
the age of the patient at the time of the Fontan procedure
(0. 374, P , .05), the serum necroinflammatory marker
(0.547, P 5 .001), and the transient elastography (0.344,
P , .05). No significant correlation could be found between
the serum fibrosis marker and the time interval since the Fon-
tan operation (0.192, P 5 .276) (Figure 2).
The necroinflammatory marker correlated significantly
with the time interval since the Fontan procedure (0.374,
P , .05) (Figure 3) and the age of the patient at the timeracic and Cardiovascular Surgery c Volume 135, Number 3 563
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Dof the present examination (0.359, P , .05). In addition, the
serum marker of necroinflammatory activity in the liver cor-
related significantly with transient elastography values
(0.480, P , .05), the retrograde flow (positive flow) in
the right hepatic vein (0.347, P , .05), and the E/A values
(0.407, P , .05).
Time Interval Since the Fontan Operation
The time interval since the Fontan operation seems to play an
important role in disease progression. In addition to the sig-
nificant correlation between the time interval since the Fontan
operation and transient elastography (0.544, P , .005), as
well as the serum necroinflammatory marker (0.374, P ,
.05), the time interval since the Fontan operation correlated
significantly with the inspiration/expiration diameter ratio
of the vena cava (0.477, P , .05) (as a sign of congestion
of the liver) and the echocardiographic parameters indicating
altered diastolic function, such as the E/A value across the
atrioventricular systemic valve (0.431, P , .01).
Conventional Sonographic Examination of the Liver
Adequate visualization of the hepatic and portal veins by
B-mode sonography and sufficient analysis of respective
flow patterns were achieved in all examined patients. How-
Figure 1. Box-plots of the time interval since the Fontan operation
for each fibrosis stage according to Metavir using transient elas-
tography. The top and bottom of the boxes represent the first and
third quartiles, respectively. The length of the box represents the
interquartile range within which 50% of values are located. The
thick line through the middle of each box represents the median.
The error bars mark the minimum andmaximum values (range).OP,
Operation.564 The Journal of Thoracic and Cardiovascular Surgery c Maever, the very young patients (n 5 7) were not able to hold
their breath. No correlation was found between the size of
the spleen and the fibrosis stage or blood parameters. All pa-
tients had a triphasic flow pattern in the right hepatic vein,
and no focal lesions were detected in the liver in any patient.
No significant correlation could be found between the
liver fibrosis stages measured with the transient elastography
or serum fibrosis marker and the blood velocity (maximum
and minimum) in the portal and right hepatic veins.
However, significant correlation was found between the
magnitude retrograde flow in the right hepatic vein and the
serum necroinflammatory marker. The laboratory values
aspartate aminotransferase (0.347, P , .05), ALT (0.495,
P , .005), and a2-macroglobulin (0.391, P , .05) were
also significant.
Discussion
Several studies have shown that the Fontan circulation may
lead to venous liver congestion and possible structural and
functional liver alteration. This can finally lead to liver cir-
rhosis with its sequelae.4,6 Hepatocellular carcinoma in
patients with liver cirrhosis after the Fontan procedure was
recently reported.4,6
Figure 2. Range diagram of the time interval since the Fontan op-
eration for each fibrosis stage according to Metavir using the se-
rum fibrosis marker. No significant correlation could be found
between the biochemical fibrosis staging using the serum fibrosis
marker and the time interval since the Fontan operation. However,
a trend can be seen in the present figure showing increasing
FibroTest (Biopredictive, Paris, France) values with increasing
time interval since the Fontan operation. OP, Operation.rch 2008
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DThe liver has not been routinely examined in patients after
the Fontan operation, because it did not seem to play a crucial
role in the morbidity and mortality in the mid- and long-term
follow-ups. In the meantime, however, life expectancy in
these patients has increased, and morbidity and mortality
caused by failing of the Fontan circulation have decreased.
The standard procedure for the staging of liver fibrosis is
the liver biopsy. However, it is ethically not justified to
perform a liver biopsy in all pediatric patients with Fontan
circulation.
Therefore, the aim of this study was to draw attention to
this important complication in the liver of these patients
with Fontan circulation using the novel noninvasive method
of transient elastography in combination with biochemical
serum fibrosis markers. By using the combination of 2 differ-
ent methods, it was possible to detect structural and func-
tional alterations that are of prognostic value in the staging
of liver fibrosis and in the identification of those patients at
risk of developing liver cirrhosis. The inverse significant cor-
relation of transient elastography values with factor V, which
Figure 3. Box-plots of the time interval since the Fontan operation
according to the grading of necroinflammatory activity using the
ActiTest (Biopredictive). Twenty-three patients had ActiTest A0
(no necroinflammatory activity), 7 patients had A0-1, 5 patients
had A1, 4 patients had A1-2, and no patient had A2, A2–3, A3,
A3–4 or A4 (severe necroinflammatory activity). A significant cor-
relation was found between the ActiTest and the time interval
since the Fontan procedure. Increasing inflammatory activity is
shown with increasing time interval since the Fontan operation.
The decrease at the highest measured grade of activity might be
due to the small number of patients in this group. OP, Operation.The Journal of Thois known to decrease with the progression of liver disease,
substantiates the use of transient elastography as a marker
of liver disease progression. Only 1 patient had clinic and so-
nographic signs of liver cirrhosis (low platelet count, low al-
bumin, elevated bilirubin, liver surface nodularity,
hypertrophy of segment I, and signs of portal hypertension).
In the present study, a significant correlation between the
fibrosis staging using transient elastography and the time in-
terval since the Fontan operation was found. The number of
patients with significant liver fibrosis after the Fontan proce-
dure increased dramatically especially at 5 years (Figure 1).
The morphologic and functional changes in the liver with
increasing time after the operation and increasing age are
simultaneous to alteration in systolic and diastolic function
of the univentricular heart.22 However, the precise patho-
physiologic mechanism leading to liver injury in association
with Fontan circulation is not clearly elucidated. The findings
of a significant correlation of the serum necroinflammatory
marker, as an indirect marker of necroinflammatory activity
(necrosis) with other studied parameters, is suggestive for he-
modynamically induced liver congestion and altered blood
flow to the pulmonary circulation. This may result in inflam-
matory activity in the liver, followed by increased fibrosis.
This assumption is supported by the significant correlation
between transient elastography values and ALT levels as
a marker of inflammation. These correlations may explain
the abnormal sonographic findings of liver morphology in
our study, which may be in part induced by long-lasting
venous liver congestion. The findings are in accordance
with previous studies reporting a correlation of the systemic
venous pressure and the duration of the Fontan circulation
with liver fibrosis and cirrhosis.4,6 Abnormal liver histology
findings have been reported in patients with failing Fontan
circulation and adults with right-sided heart failure.23,24
The pathologic substrate seems to be similar. The conges-
tive hemodynamic process usually starts in the form of
sinusoidal dilatation, parenchymal atrophy, and progressive
sinusoidal collagen deposition in the perivenular distribu-
tion. With long-lasting congestive effect, these morphologic
changes advance leading to profound alterations in liver
architecture and diffuse sinusoidal fibrosis and cirrho-
sis.23,24 The abnormal hemodynamic conditions of passive
low flow associated with liver venous congestion in the pa-
tients with Fontan circulation may result in the same path-
ophysiologic mechanisms of liver fibrosis and cirrhosis.
Alterations of pulmonary resistance may be equally impor-
tant; however, because of the noninvasive character of the
present study, simultaneous invasive hemodynamic mea-
surements of pulmonary arterial pressure and resistance
were not performed.
Limitations
At present, liver biopsy is still the reference standard for the
assessment of liver fibrosis. Therefore, a limitation of theracic and Cardiovascular Surgery c Volume 135, Number 3 565
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methods with simultaneous histologic assessment of liver
fibrosis by liver biopsy. However, the accuracy of liver
biopsy is limited because of intra- and interobserver vari-
ability and sampling errors.8 A study of more than 10,000
virtual biopsies by Bedossa and colleagues8 showed that
liver fibrosis stage is correctly diagnosed in only 65% of
cases if the biopsy is at least 15 mm long and in 75% of
cases if the biopsy is at least 25 mm long, and the optimal
size should be 40 mm. However, most biopsies do not ful-
fill these optimal criteria even at large hepatology centers.20
The ultimate validation of liver fibrosis as a marker of liver
injury is its prognostic value in terms of morbidity and
mortality. In a recently published study, the serum fibrosis
marker was shown to have a 5-year prognostic value similar
to that of liver biopsy.25 Therefore, noninvasive methods of
liver fibrosis may not be inferior to liver biopsy for the
assessment of liver fibrosis. Thus, in the present study it
did not seem to be ethically justified to perform a liver
biopsy in these young children.
After the Fontan operation, patients have systolic and di-
astolic myocardial dysfunction, and abnormal venous and
arterial hemodynamics that lead to congestion in the liver.26
The increased systemic venous pressure leads to congestion
in the liver, which is per se associated with an increased
stiffness of the liver. Previously, no studies have evaluated
transient elastography for the staging of liver fibrosis in
patients with congestive liver disease. An overestimation
of the liver fibrosis stage is expected in these patients be-
cause of the increased blood volume in the liver. This ex-
plains the differences in the assignment of fibrosis stages
between the transient elastography and the fibrosis marker
score in the present study. The mean fibrosis stage was
2.9 6 1.1 using transient elastography and 1.7 6 1.0 using
the serum fibrosis marker. The biochemical serum fibrosis
marker is independent from the congestion in the liver. Be-
cause a significant correlation was found between the serum
fibrosis marker and the transient elastography values, an
overestimation of transient elastography of approximately
1 fibrosis stage is assumed.
Transient elastography might be especially useful for indi-
vidual follow-up, in which an increase of transient elastogra-
phy value can be interpreted as a sign for the progression of
liver fibrosis. However, longitudinal studies are necessary to
support this assumption. The results need to be interpreted
taking into account the results of hemodynamic examinations
and the quantitative assessment of systolic and diastolic uni-
ventricular function. The detectable liver changes in the pres-
ent study measured with transient elastography and the
fibrosis marker score do not seem to be directly related to
altered univentricular function. Because of the noninvasive
characteristic of this study, simultaneous invasive hemody-
namic measurements of pulmonary arterial pressure and
resistance were not performed. We speculate that the passive566 The Journal of Thoracic and Cardiovascular Surgery c Maslow flow in the Fontan circulation without the physiologic
antegrade pump function may be responsible for the fibrotic
changes in these patients.
Conclusions
This is at present the largest prospective cross-sectional epi-
demiologic study showing that patients who have undergone
the Fontan procedure are at risk of developing liver fibrosis
and cirrhosis with its sequelae. This study shows that this
risk increases with the time interval since the Fontan opera-
tion and the age of the patient. Noninvasive methods, such
as transient elastography and fibrosis marker scores, seem
to be useful tools to assess liver fibrosis in these patients
and may be helpful to recognize a progression of the liver
disease during routine follow-up. Therefore, assessment of
liver structure and function using transient elastography
and fibrosis marker scores should be included in the long-
term follow-up of patients with Fontan circulation. Such
screening programs may have significant consequences
when patients with failing Fontan circulation are candidates
for orthotopic heart and/or liver transplantation.
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